Raffaele Califano(@caliraf) 's Twitter Profileg
Raffaele Califano

@caliraf

Thoracic Oncologist @TheChristieNHS, Honorary Professor @UoM_DCS .
Member @myesmo Educational Publication WG.
Views are my own
No DMs or medical advice given.

ID:273407022

calendar_today28-03-2011 12:44:56

988 Tweets

942 Followers

454 Following

Bishal Gyawali(@oncology_bg) 's Twitter Profile Photo

The most important video I’ve made for early career academics starting to do peer review.
Nobody teaches how to do a good peer review but you are suddenly invited to do a peer review. So how to be a good peer reviewer?
Here is my advice-

youtu.be/ftstYE9hbCI

account_circle
Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ(@APassaroMD) 's Twitter Profile Photo

🛎 just published in NEJM our editorial on the groundbreaking ALINA trial, evaluating the role of adjuvant alectinib in patients with resected NSCLC carrying ALK rearrangements.
A major advance for our patients!
🔗nejm.org/doi/full/10.10…

🛎 just published in @NEJM our editorial on the groundbreaking ALINA trial, evaluating the role of adjuvant alectinib in patients with resected NSCLC carrying ALK rearrangements. A major advance for our patients! 🔗nejm.org/doi/full/10.10…
account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Among patients without baseline brain metastases, incidence of brain metastases at 5 years was 42.3%. Stresses importance of routine CNS imaging for pts with mutant NSCLC to detect these early and the need for better CNS control with our regimens.

Among patients without baseline brain metastases, incidence of brain metastases at 5 years was 42.3%. Stresses importance of routine CNS imaging for pts with #EGFR mutant NSCLC to detect these early and the need for better CNS control with our regimens.
account_circle
ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo

📢New edition of ' : Essentials for Clinicians' now available. This is mainly addressed towards junior doctors but is also suitable for general oncologists or haematologists who want to stay updated. ow.ly/FGCt50R1lqk
Ivana Božović Raffaele Califano Tania Fleitas Kanonnikoff

📢New edition of '#Lymphomas: Essentials for Clinicians' now available. This #ESMOBook is mainly addressed towards junior doctors but is also suitable for general oncologists or haematologists who want to stay updated. ow.ly/FGCt50R1lqk @bozovicspa @caliraf @tfleitask…
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Great presentation of long term outcomes in the CONVERT trial by ⁦Gerard Walls
▶️1/3 patients alive at 5 yrs
▶️low rates of late toxicity
▶️BD RT remains standard of care in LS-SCLC
The Christie NHS⁩ ⁦Manchester Cancer Research Centre⁩ ⁦⁦⁦⁦Science and Innovation at Cancer Research UK

Great presentation of long term outcomes in the CONVERT trial by ⁦@gwalls89⁩ #ELCC24 ▶️1/3 patients alive at 5 yrs ▶️low rates of late toxicity ▶️BD RT remains standard of care in LS-SCLC ⁦@TheChristieNHS⁩ ⁦@MCRCnews⁩ ⁦⁦⁦⁦@CRUKresearch⁩
account_circle
Kathryn Banfill 💙(@KathrynBanfill) 's Twitter Profile Photo

Corinne Faivre-Finn 💙 The Christie NHS Manchester Cancer Research Centre In these complex situations joint assessment between surgeons and oncology such as the Manchester is great for patients and clinicians. Clinic also has prehab4cancer and geriatric oncology to further enhance decision making and patient experience

@finn_corinne @TheChristieNHS @MCRCnews In these complex situations joint assessment between surgeons and oncology such as the Manchester #OneStopClinic is great for patients and clinicians. Clinic also has @prehab4cancer and geriatric oncology to further enhance decision making and patient experience
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Well done Clara for an excellent and convincing presentation. The PACIFIC regimen was definitely the way to go for the presented stage III bulky N2 case The Christie NHS Manchester Cancer Research Centre

Well done Clara for an excellent and convincing presentation. The PACIFIC regimen was definitely the way to go for the presented stage III bulky N2 case #ELCC24 @TheChristieNHS @MCRCnews
account_circle
Jarushka Naidoo(@DrJNaidoo) 's Twitter Profile Photo

Real-World Data in Oncology: A Call for Standards Journal of Clinical Oncology

Nice editorial on what constitutes rigorous RWD:
- fit for purpose: do the data answer the quesn?
- data provenance: trail of origin
- data transparency: accessible/understandable

OncoAlert
ascopubs.org/doi/10.1200/JC…

account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Looking forward to a great debate against Jonathan Spicer MD PhD on Friday 22/3 10.30 South Hall 2
Stage III NSCLC-Resect or Radiate?
Will there be blood on the carpet?

Looking forward to a great debate against @DoctorJSpicer on Friday 22/3 10.30 South Hall 2 #ELCC24 Stage III NSCLC-Resect or Radiate? Will there be blood on the carpet?
account_circle
Dr. Antonio Calles 🫁🚭(@Tony_Calles) 's Twitter Profile Photo

Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ giving a tour de force on EGFR exon 20 mutation for patients with lung 🫁 cancer and new treatment options for these patients discussing current SoC Amivantamab + chemotherapy. ESMO - Eur. Oncology

@APassaroMD giving a tour de force on EGFR exon 20 mutation for patients with lung 🫁 cancer and new treatment options for these patients discussing current SoC Amivantamab + chemotherapy. #ELCC24 #LCSM @myESMO #ESMOAmbassadors
account_circle